The bill significantly impacts state law regarding health insurance requirements by mandating that certain pediatric conditions receive coverage. This alteration reflects an important policy shift towards recognizing and addressing specific pediatric health needs. Furthermore, health insurance carriers in Rhode Island will also be responsible for collecting and reporting data on the costs and potential savings associated with this coverage to the office of the health insurance commissioner by January 1, 2025. This report will evaluate the effectiveness and financial impact of the new mandate on both insurers and policyholders.
Summary
Bill S0024 is a legislative measure focused on ensuring mandatory health insurance coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome. Effective from January 1, 2023, every group health insurance contract and policy in Rhode Island will be required to include coverage for these disorders, including advanced treatment options such as intravenous immunoglobin therapy. The bill aims to address a significant gap in healthcare coverage for affected children and ensures they receive necessary medical interventions.
Contention
While proponents of the bill argue it is a crucial step to ensure vulnerable children have access to necessary treatments, potential concerns have been raised regarding the financial implications for insurance carriers. The bill contains a sunset provision set for December 31, 2025, which suggests that its impact will be reviewed before continuing indefinitely. This could lead to ongoing discussions about funding and coverage as the healthcare landscape evolves. Critics may worry about the added burdens on the insurance marketplace and the long-term sustainability of funded treatments as the analysis unfolds.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
An Act to amend and reenact ยงยง 38.2-3418.21 and 38.2-3418.22 of the Code of Virginia, relating to Bureau of Insurance; essential health benefits benchmark plan selection.
Extends coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome by removing the sunset date of December 31, 2025, and mandating such coverage.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
A bill for an act relating to health insurance coverage for specified pediatric autoimmune neuropsychiatric disorders and postinfectious autoimmune encephalopathy.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Extends coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome by removing the sunset date of December 31, 2025, and mandating such coverage.
Human services: medical services; coverage for the prophylaxis, diagnosis, and treatment of certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1939 PA 280 (MCL 400.1 - 400.119b) by adding sec. 109v.